Trial-In-Progress: A Pilot Study Of Combined Immune Checkpoint Inhibition In Combination With Ablative Therapies In Subjects With Hepatocellular Carcinoma (Hcc).

Hailey Kathryn Carroll,Umair Aleem,Pooja Varghese,Marie Galligan,Michele Bourke,Katherine Hoey,Ronan Ryan,Peter Doran,Stephen Stewart,Cliona O'Farrelly,Tim F. Greten,Diarmaid Houlihan,Raymond S. McDermott,Austin G. Duffy

Journal for ImmunoTherapy of Cancer（2021）

引用 3|浏览22

暂无评分

摘要

TPS355Background: Locoregional therapies for hepatocellular carcinoma, such as transcatheter arterial chemoembolization (TACE) or ablation, can induce a peripheral anti-tumor immune response. This ...

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要